Optiver Holding
ACAD icon

Optiver Holding’s Acadia Pharmaceuticals ACAD Stock Holding History

Optiver Holding’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.3K Buy
+921
New +$20.3K ﹤0.01% 1462

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Optiver Holding's ACAD Position: Q2 2026 in Review

Optiver Holding opened a new position in Acadia Pharmaceuticals (ACAD) in Q2 2026: 921 shares worth $23.3K. The stake represents ﹤0.01% of the portfolio and ranks #1462 among its holdings.

352 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • Optiver Holding held 921 shares of Acadia Pharmaceuticals worth $23.3K as of Q2 2026.
  • Acadia Pharmaceuticals was a new Optiver Holding position in Q2 2026.
  • Acadia Pharmaceuticals made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1462 holding.
  • 352 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.